- Home
- OMCL vs NEO Comparison
OMCL vs NEO Comparison
Compare OMCL & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- NEO
- Stock Information
- Founded
- OMCL 1992
- NEO 2001
- Country
- OMCL United States
- NEO United States
- Employees
- OMCL N/A
- NEO N/A
- Industry
- OMCL Computer Manufacturing
- NEO Precision Instruments
- Sector
- OMCL Technology
- NEO Health Care
- Exchange
- OMCL Nasdaq
- NEO Nasdaq
- Market Cap
- OMCL 2.0B
- NEO 2.3B
- IPO Year
- OMCL 2001
- NEO 1999
- Fundamental
- Price
- OMCL $42.54
- NEO $14.11
- Analyst Decision
- OMCL Buy
- NEO Strong Buy
- Analyst Count
- OMCL 6
- NEO 10
- Target Price
- OMCL $50.00
- NEO $20.56
- AVG Volume (30 Days)
- OMCL 489.8K
- NEO 1.2M
- Earning Date
- OMCL 02-06-2025
- NEO 02-18-2025
- Dividend Yield
- OMCL N/A
- NEO N/A
- EPS Growth
- OMCL N/A
- NEO N/A
- EPS
- OMCL N/A
- NEO N/A
- Revenue
- OMCL $1,064,205,999.00
- NEO $644,118,000.00
- Revenue This Year
- OMCL N/A
- NEO $12.98
- Revenue Next Year
- OMCL $5.24
- NEO $9.94
- P/E Ratio
- OMCL N/A
- NEO N/A
- Revenue Growth
- OMCL N/A
- NEO 12.06
- 52 Week Low
- OMCL $25.12
- NEO $12.13
- 52 Week High
- OMCL $55.75
- NEO $19.11
- Technical
- Relative Strength Index (RSI)
- OMCL 42.67
- NEO 39.96
- Support Level
- OMCL $41.87
- NEO $13.93
- Resistance Level
- OMCL $45.38
- NEO $14.77
- Average True Range (ATR)
- OMCL 1.14
- NEO 1.11
- MACD
- OMCL -0.04
- NEO -0.28
- Stochastic Oscillator
- OMCL 29.35
- NEO 28.37
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.